Stay in the loop with periodic emails on breaking developments and noteworthy events from PATH's Malaria Vaccine Initiative (MVI). These are delivered to your email inbox no more than four times yearly.
We also invite you to subscribe to two new quarterly newsletters—Immunization Matters and Moving the Needle—to provide you with a better picture of the breadth of PATH’s vaccine work across disease areas, including malaria, and across the vaccine development and introduction spectrum.
Immunization Matters provides quarterly updates from PATH’s Center for Vaccine Innovation and Access (CVIA) on late-stage and licensed vaccines included in our portfolio as well as our work on health economics and optimization, operations research, and support to countries. It includes updates on our progress, partnerships, and specific activities.
Read more about Immunization Matters here.
Moving the Needle provides quarterly updates regarding CVIA's vaccine development efforts, as well as related supporting work, such as designing human challenge models, building capacity of developing-country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine technologies. It includes updates on our progress, partnerships, and specific activities.
Read more about Moving the Needle here.